Clinical Trials Browser

Phase 2 × relmacabtagene autoleucel × 90 days × Clear all

NCT07326371 2026-01-08

Glofitamab Combined With CAR-T Therapy in R/R DLBCL

Phase 2 Not yet recruiting

Dendritic Cell Sarcoma, Interdigitating